To further confirm the possible effect of Sestrin 1 in cardiac hypertrophy, we investigated the ‘gain and loss’ phenotype of Sestrin 1 in PE‐triggered cardiomyocytes hypertrophy. This evidence concerns the gene SESN1 and cardiac hypertrophy.